Henry Schein (NASDAQ:HSIC) Given New $90.00 Price Target at Barrington Research

Henry Schein (NASDAQ:HSIC) had its target price boosted by Barrington Research from $82.00 to $90.00 in a report issued on Thursday morning,Benzinga reports. They currently have an outperform rating on the stock. Barrington Research also issued estimates for Henry Schein’s Q1 2025 earnings at $1.06 EPS, Q2 2025 earnings at $1.20 EPS, Q3 2025 earnings at $1.22 EPS, Q4 2025 earnings at $1.37 EPS and FY2025 earnings at $4.85 EPS.

Several other analysts have also recently weighed in on HSIC. StockNews.com upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Bank of America raised Henry Schein from an “underperform” rating to a “buy” rating and lifted their price target for the stock from $69.00 to $84.00 in a research note on Monday, January 6th. Jefferies Financial Group increased their price objective on Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research report on Thursday, January 23rd. Evercore ISI boosted their target price on Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 8th. Finally, Mizuho started coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price target on the stock. Seven investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $80.10.

Henry Schein Price Performance

NASDAQ:HSIC opened at $80.03 on Thursday. Henry Schein has a 52-week low of $63.67 and a 52-week high of $82.63. The stock has a fifty day moving average of $73.31 and a 200 day moving average of $71.34. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The firm has a market capitalization of $9.98 billion, a price-to-earnings ratio of 32.93, a P/E/G ratio of 2.20 and a beta of 0.89.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.17 by $0.05. The firm had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company’s revenue for the quarter was up .4% on a year-over-year basis. During the same quarter last year, the company posted $1.32 EPS. On average, research analysts expect that Henry Schein will post 4.74 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, COO Michael S. Ettinger sold 12,240 shares of Henry Schein stock in a transaction that occurred on Monday, November 18th. The shares were sold at an average price of $75.00, for a total transaction of $918,000.00. Following the completion of the transaction, the chief operating officer now directly owns 87,706 shares in the company, valued at approximately $6,577,950. This trade represents a 12.25 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 1.14% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the stock. Cromwell Holdings LLC increased its holdings in shares of Henry Schein by 93.4% during the third quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock valued at $26,000 after acquiring an additional 170 shares in the last quarter. Versant Capital Management Inc grew its position in Henry Schein by 274.6% during the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $32,000 after purchasing an additional 335 shares during the last quarter. Quent Capital LLC increased its stake in Henry Schein by 91.2% during the 4th quarter. Quent Capital LLC now owns 677 shares of the company’s stock valued at $47,000 after purchasing an additional 323 shares in the last quarter. City State Bank purchased a new position in Henry Schein in the fourth quarter worth about $55,000. Finally, Farther Finance Advisors LLC lifted its stake in shares of Henry Schein by 58.9% in the third quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock worth $68,000 after buying an additional 346 shares in the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.